Dysregulated bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling are key initiators of EndMT in PAH (Gaikwad et al., 2020). The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.